首页 | 本学科首页   官方微博 | 高级检索  
     

紫杉醇脂质体治疗晚期非小细胞肺癌的临床观察
引用本文:张华,翟福林. 紫杉醇脂质体治疗晚期非小细胞肺癌的临床观察[J]. 中国肿瘤临床与康复, 2011, 0(5): 435-437
作者姓名:张华  翟福林
作者单位:郴州第一人民医院南院肿瘤科;
摘    要:目的探讨紫杉醇脂质体联合顺铂治疗晚期非小细胞肺癌(NSCLC)的临床疗效及毒性反应。方法紫杉醇脂质体135 mg/m2加入5%葡萄糖注射液500 ml中,静脉滴入3 h,d1;DDP 25mg/m2加入生理盐水500 ml中,静脉滴入dl~d3。21~28 d为1周期。化疗2~4周期,观察近期临床疗效、不良反应。结果本组76例患者均完成2~4周期治疗,其中CR 3例,PR 33例,SD 34例,PD 6例,有效率(CR+PR)36例(47.37%),化疗后出现白细胞减少患者占100.0%(76/76),Ⅲ、Ⅳ度反应仅占21.05%(16/76);血红蛋白下降患者占28.94%(22/76);胃肠道反应占57.89%(44/76);疲乏无力发生率56.58%(43/76);脱发占15.79%(12/76)。结论紫杉醇脂质体联合顺铂治疗晚期NSCLC是一种疗效高,毒副作用可耐受的化疗方案。

关 键 词:非小细胞肺癌  紫杉醇脂质体  顺铂

Clinical observation of paclitaxelum lisposome with platinum for advanced non-small cell lung cancer
ZHANG Huan,ZHAI Fu-lin. Clinical observation of paclitaxelum lisposome with platinum for advanced non-small cell lung cancer[J]. Chinese Journal of Clinical Oncology and Rehabilitation, 2011, 0(5): 435-437
Authors:ZHANG Huan  ZHAI Fu-lin
Affiliation:ZHANG Huan,ZHAI Fu-lin(Department of Oncology,The First People Hospital of Chenzhou,Chenzhou 423000,China)
Abstract:Objective To study the efficacy and toxic reaction of paclitaxelum liposome with cis-platinum for advanced stage non-small cell lung cancer(N-SCLC).Methods A total of 76 case with non-small cell lung cancer were treated by TP scheme.Add 135 mg/m paclitaxelum lipid body in 500 ml 5% Glucose liquid vein drop d1-d3.the patients were repeatedly treated every 21 or 28 days.the efficacy and toxicity were evaluated after no leas than 2-4 cycles.Results CR 3 cases,PR 33 cases,SD 34 cases,PD 6 cases.Total CR and PR ...
Keywords:Non-small celllung cancer  Paclitaxelum liposome  Cis-platinum  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号